The Marcus(US:MCS)2026-02-26 17:02Financial Data and Key Metrics Changes - Consolidated revenues for Q4 of fiscal 2025 were $193.5 million, a 2.8% increase year-over-year, with revenue growth in both divisions [5] - Fourth quarter operating income was $1.7 million, negatively impacted by $5.2 million of non-cash impairment charges in the theater division; adjusted operating income was $6.9 million, a 5.2% increase from the previous year [5][7] - Consolidated adjusted EBITDA for Q4 was $26.8 million, a 3.6% increase compared to the prior year [6] - For the full year, consolidated revenues increased just over 3%, while adjusted EBITDA decreased 3.1% to $99.3 million [7][8] Business Line Data and Key Metrics Changes Theatres Division - Q4 revenue for the theatres division was $123.8 million, a 2.2% increase year-over-year, with a favorable shift in the fiscal calendar contributing to revenue growth [8][9] - Comparable theater admission revenue increased 6.1% over the prior year, while attendance decreased 5.7% [9][10] - Average admission price increased by 12.7% due to strategic pricing actions [10] - Adjusted EBITDA for the theatre division was $24.1 million, just under a 2 percentage point increase compared to the prior year [12] Hotels and Resorts Division - Q4 revenue before cost reimbursements was $60.4 million, a 5% increase year-over-year [12] - RevPAR for owned hotels grew 3.5% during Q4, despite a 1.2 percentage point decrease in occupancy rate [13][14] - Adjusted EBITDA for the hotels division was $7.3 million, an increase of 3.4% compared to the prior year [16] Market Data and Key Metrics Changes - Theatres outperformed the U.S. box office, which decreased by 1.5% during Q4, indicating a 7.6 percentage point outperformance [10] - Hotels outperformed the upper upscale segment, which saw a RevPAR increase of 0.8% [14][15] Company Strategy and Development Direction - The company plans to decrease capital expenditures significantly in 2026, focusing on maintenance and ROI investments in hotels and enhancing customer experience in theatres [19][20] - The company aims to return capital to shareholders while seeking growth opportunities [20][21] - The 2026 film slate is expected to include several strong titles, which could enhance box office performance [36] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about growth opportunities in 2026, particularly in the theatres division due to a favorable film slate [24][36] - The company noted that the demand environment for hotels was mixed, but upper upscale properties performed well [40] - Management highlighted the importance of maintaining a steady product supply in theatres to support attendance [27] Other Important Information - The company ended Q4 with over $23 million in cash and $230 million in total liquidity, with a debt-to-capitalization ratio of 26% [19] - Share repurchases totaled approximately 1.1 million shares for $18 million in cash during fiscal 2025 [18] Q&A Session Summary Question: What should be expected regarding pricing strategy in the theatre segment for 2026? - Management indicated that the focus will be on the anniversary of price changes made in mid-2025, with an emphasis on driving per capita sales in food and beverage [48][49] Question: What is the outlook for leisure versus business travel bookings in hotels for 2026? - Management noted that group bookings remain healthy, with leisure demand performing well, particularly in renovated properties [50][52] Question: What are the company's thoughts on M&A activity? - Management acknowledged the slow hotel transaction market but indicated a willingness to explore opportunities in both hotels and theatres [69][72] Question: How does the company view its asset portfolio and potential divestitures? - Management stated that they continuously evaluate their assets and are open to divestitures if it aligns with long-term strategy [80][81]